Performance status and deaths among children registered in Kuwait National Primary Immunodeficiency disorders registry

Asian Pacific Journal of Allergy and Immunology

Volumn 28, Issue 2-3, 2010, Pages 141-146

  Al Herz, Waleed ^a   Zainal, Mohammad E ^a   Alenezi, Hamid M ^a   Husain, Khalid ^a   Alshemmari, Salem H ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Cytomegalovirus; Immunoglobulins; Mortality; Primary immunodeficiency; Quality of life

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOGLOBULIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHILDHOOD MORTALITY; COMORBIDITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRIMARY IMMUNODEFICIENCY DISORDER; REGISTRATION; RISK FACTOR; SCORING SYSTEM;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; KUWAIT; MALE; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 78649497461     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ochs HD, Stiehm R, Winkelstein J. Antibody Deficiencies. In: ER Stiehm, HD Ochs, JA Winkelstein, eds. Immunologic Disorders in Infants & Children 5th ed., Philadelphia, Elsevier Saunders, 2004; pp. 356-426.
2. Cunningham-Rundles C, Bodian C. Common Variable Immunodeficiency: Clinical and Immunological Features of 248 Patients. J Clin Immunol 1999; 92: 34-48.
3. Stiem ER, Chin TW, Hass A, Peerless AG. Infectious complications of primary immunodeficiencies. Clin Immunol Immunopathol 1986; 40: 69-89.
4. Webster ADB. Infections in primary immunodeficiency syndrome. Curr Opin Infect Dis 1994; 7: 444-9.
5. Antoine C, Muller S, Cant A, et al. European Group for Blood and Marrow Transplantatoin; European Society for Immunodeficiency. Longterm survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003; 361: 553-60.
6. Mazzolari E, Forino C, Guerci S, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol 2007; 120: 892-9.
7. Grunebaum E, Mazzolari E, Porta F, et al. Bone marrow transplantation for severe combined immunodeficiency. JAMA 2006; 295: 508-18.
8. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109: 1001-4.
9. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 2007; 27:497-502.
10. Chapel HM, Misbah S, Webster ADB. Assessment of the Immune System. In: HD Ochs, CIE Smith, JM Puck, eds. Primary Immunodeficiency Diseases a Molecular and Genetic Approach 2nd ed., New York, Oxford University Press, 2007; pp. 611-32.
11. Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004-2006). J Clin Immunol 2008; 28: 186-93.
12. Eades-Perner AM, Gathmann B, Knerr V, et al. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol 2007; 147: 306-12.
13. Rezaei N, Aghamohammadi A, Moin M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol 2006; 26: 519-32.
14. Geha RS, Notarangelo LD, Cassanova JL, et al. Primary immunodeficiency diseases: an update form the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007; 120: 776-94.
15. Villa A, Sobacchi C, Notarangelo LD, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood 2001; 97: 81-8.
16. Dorman SE, Picard C, Lamas D, et al. Clinical features of dominant and recessive interferon gammareceptor 1 deficiencies. Lancet 2004; 364: 2113-21.
17. Jin Y, Mazza C, Christie JR, et al. Mutation of the Wischott- Aldrich Syndrome Protien (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 2004; 104: 4010-9.
18. Sigstad HM, Stray-Pederson A, Froland SS. Coping, quality of life, and hope in adults with primary antibody deficiencies. Health Qual Life Outcomes 2005; 3: 31-44.
19. Gardulf A, Nicolay U, Math D, et al. Children and adults with primary immunodeficiencies gain quality of life by subcutaneous IgG selfinfusions at home. J Allergy Clin Immunol 2004; 114: 934-5.
20. Tcheurekdjian H, Palermo T, Hostoffer R. Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy. Ann Allergy Asthma Immunol 2004; 93: 160-5.
21. Zebracki K, Palermo TM, Hostoffer R, Duff K, Drotar D. Health-related quality of life of children with primray immunodeficiency diseases: a comparison study. Ann Allergy Asthma Immunol 2004; 93: 557-61.
22. Nicolay U, Kiessling P, Berger M, et al. Health-related quality of life and treatment satisfaction in North American patients with primary immunodeficiency diseases receiving subcutaneous IgG self-infusion at home. J Clin Immunol 2006; 26: 65-72.
23. Mozaffari H, Pourpak Z, Pourseyed S, et al. Health-related quality of life in Primary immune deficient patients. Iran J Allergy Asthma Immunol 2006; 5: 23-7.
24. Nicolay U, Haag S, Eichmann F, Hergert S, Spruck D, Gardulf A. Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapy. Qual Life Res 2005; 14: 1683-91.
25. Mir Saeid Ghazi B, Aghamohammadi A, Kouhi A, et al. Mortality in primary immunodeficient patients, registered in Iranian primary immunodeficiency registry. Iran J Allergy Asthma Immunol 2004; 3: 31-6.
26. Lansky SB, List MA, Lansky LL, Ritter-sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer 1987; 60: 1651-6.
27. Aghamohammadi A, Pouladi N, Parvaneh N, et al. Mortality and morbidity in common variable immunodeficiency. J Trop Pediatr 2007; 53: 32-8.
28. Wood P, Stanworth S, Burton J, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systemic review. Clin Exp Immunol 2007; 149: 410-23.
29. Quinti I, Soresina A, Spadaro G, et al. Long term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27: 308-16.
30. Joshi AY, Iyer VN, Hagan JB, Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc 2009; 84: 16-22.
31. Leiva LE, Zelazco M, Oleastro M, et al. Primary Immunodeficiency Diseases in Latin America: The Second Report of the LAGID registry. J Clin Immunol 2007; 27: 101-8.
32. Lee WI, Kuo ML, Huang JL, Lin SJ, Wu CJ. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol 2005; 25: 162-73.
33. Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J Clin Immunol 2005; 25: 73-7.
34. Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of immunodeficiency disorders in Australia. J Allergy Clin Immunol 1997; 100: 415-23.
35. Al-Awadi SA, Moussa MA, Naguib KK, et al. Consanguinity among the Kuwaiti population. Clin Genet 1985; 27: 483-6.